[
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
[og_img]
https://www.investing.com/news/press-releases/zealand-pharma-announces-completion-of-enrollment-in-the-phase-2b-zupreme1-trial-of-petrelintide-in-people-with-overweight-or-obesity-93CH-3931184
Investing.com
Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity
Related articles
